Back
Protagonist Therapeutics Stock Price Chart
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
43.12
Seasonality Move:
12.96%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More Here- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
Protagonist Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.65 | Sell |
| 20-day SMA: | 46.93 | Sell |
| 50-day SMA: | 45.52 | Buy |
| 200-day SMA: | 35.08 | Buy |
| 8-day EMA: | 46.78 | Sell |
| 20-day EMA: | 46.56 | Sell |
| 50-day EMA: | 44.99 | Buy |
| 200-day EMA: | 36.42 | Buy |
Protagonist Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 50.93 | Buy |
| Chaikin Money Flow: | -517429 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.04 - 47.68) | Buy |
| Bollinger Bands (100): | (36.66 - 46.32) | Buy |
Protagonist Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Protagonist Therapeutics Stock
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 46.50 while PTGX 8-day simple moving average is 46.65, which is a Sell signal.
- The stock price of PTGX is 46.50 while Protagonist Therapeutics 20-day SMA is 46.93, which makes it a Sell.
- Protagonist Therapeutics 50-day simple moving average is 45.52 while PTGX share price is 46.50, making it a Buy technically.
- PTGX stock price is 46.50 and Protagonist Therapeutics 200-day simple moving average is 35.08, creating a Buy signal.
PTGX Technical Analysis vs Fundamental Analysis
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy or a Sell?
-
Protagonist Therapeutics stock is rated a Sell
The current Protagonist Therapeutics [PTGX] share price is $46.50. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Protagonist Therapeutics Stock Info
Market Cap:
2.77B
Price in USD:
46.50
Share Volume:
558.13K
Protagonist Therapeutics 52-Week Range
52-Week High:
48.89
52-Week Low:
15.05
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Protagonist Therapeutics Share Price Forecast
-
What is the Protagonist Therapeutics stock price today?
The Protagonist Therapeutics stock price is 46.50 USD today. -
Will PTGX stock go up or go down?
Protagonist Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protagonist Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protagonist Therapeutics is overvalued.
Is Protagonist Therapeutics Stock a Buy?
- Protagonist Therapeutics share price is 46.50 while PTGX 8-day exponential moving average is 46.78, which is a Sell signal.
- The stock price of PTGX is 46.50 while Protagonist Therapeutics 20-day EMA is 46.56, which makes it a Sell.
- Protagonist Therapeutics 50-day exponential moving average is 44.99 while PTGX share price is 46.50, making it a Buy technically.
- PTGX stock price is 46.50 and Protagonist Therapeutics 200-day simple moving average is 36.42, creating a Buy signal.
Fundamental Analysis of Protagonist Therapeutics
Is Protagonist Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.24 per share, and a decrease next year of $5.00 per share.
Technical Analysis of Protagonist Therapeutics
Should I short Protagonist Therapeutics stock?
- PTGX Moving Average Covergence Divergence (MACD) indicator is 0.44, suggesting Protagonist Therapeutics is a Buy
- Protagonist Therapeutics Relative Strength Index (RSI) is 50.93, which suggest Protagonist Therapeutics is overbought
- The Bollinger Bands (25) for Protagonist Therapeutics is (45.04 - 47.68), which suggest Protagonist Therapeutics is a Buy
- The Bollinger Bands (100) for Protagonist Therapeutics is (36.66 - 46.32), which suggest Protagonist Therapeutics is a Buy
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.